Original language | English (US) |
---|---|
Pages (from-to) | 2360-2363 |
Number of pages | 4 |
Journal | Blood Advances |
Volume | 7 |
Issue number | 11 |
DOIs | |
State | Published - Jun 13 2023 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Blood Advances, Vol. 7, No. 11, 13.06.2023, p. 2360-2363.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Pevonedistat with azacitidine in older patients with TP53-mutated AML
T2 - a phase 2 study with laboratory correlates
AU - Saliba, Antoine N.
AU - Kaufmann, Scott H.
AU - Stein, Eytan M.
AU - Patel, Prapti A.
AU - Baer, Maria R.
AU - Stock, Wendy
AU - Deininger, Michael
AU - Blum, William
AU - Schiller, Gary J.
AU - Olin, Rebecca L.
AU - Litzow, Mark R.
AU - Lin, Tara L.
AU - Ball, Brian J.
AU - Boyiadzis, Michael M.
AU - Traer, Elie
AU - Odenike, Olatoyosi
AU - Arellano, Martha L.
AU - Walker, Alison
AU - Duong, Vu H.
AU - Kovacsovics, Tibor
AU - Collins, Robert H.
AU - Shoben, Abigail B.
AU - Heerema, Nyla A.
AU - Foster, Matthew C.
AU - Peterson, Kevin L.
AU - Schneider, Paula A.
AU - Martycz, Molly
AU - Gana, Theophilus J.
AU - Rosenberg, Leonard
AU - Marcus, Sonja
AU - Yocum, Ashley O.
AU - Chen, Timothy
AU - Stefanos, Mona
AU - Mims, Alice S.
AU - Borate, Uma
AU - Burd, Amy
AU - Druker, Brian J.
AU - Levine, Ross L.
AU - Byrd, John C.
AU - Foran, James M.
N1 - Funding Information: Acknowledgments: The work was supported by the Leukemia & Lymphoma Society and by grants from the National Cancer Institute, National Institutes of Health (R01 CA225996) (S.H.K.) and the National Cancer Institute, National Institutes of Health (R35 CA198183 and support grant P30 CA008748) (J.C.B.).
PY - 2023/6/13
Y1 - 2023/6/13
UR - http://www.scopus.com/inward/record.url?scp=85163428282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163428282&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2022008625
DO - 10.1182/bloodadvances.2022008625
M3 - Letter
C2 - 36315007
AN - SCOPUS:85163428282
SN - 2473-9529
VL - 7
SP - 2360
EP - 2363
JO - Blood Advances
JF - Blood Advances
IS - 11
ER -